<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Am Soc Nephrol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Am. Soc. Nephrol</journal-id>
<journal-id journal-id-type="hwp">jnephrol</journal-id>
<journal-id journal-id-type="pmc">jnephrol</journal-id>
<journal-id journal-id-type="publisher-id">ASN</journal-id>
<journal-title-group>
<journal-title>Journal of the American Society of Nephrology : JASN</journal-title>
</journal-title-group>
<issn pub-type="ppub">1046-6673</issn>
<issn pub-type="epub">1533-3450</issn>
<publisher>
<publisher-name>American Society of Nephrology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29061652</article-id>
<article-id pub-id-type="pmc">5791057</article-id>
<article-id pub-id-type="publisher-id">2017040385</article-id>
<article-id pub-id-type="doi">10.1681/ASN.2017040385</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Basic Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus–Driven Hypertension in Diverse Diabetic Models</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Harlan</surname>
<given-names>Shannon M.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heinz-Taheny</surname>
<given-names>Kathleen M.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sullivan</surname>
<given-names>John M.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Tao</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>Hana E.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jaqua</surname>
<given-names>Dianna L.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qi</surname>
<given-names>Zhonghua</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cramer</surname>
<given-names>Martin S.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shiyanova</surname>
<given-names>Tatiyana L.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Breyer</surname>
<given-names>Matthew D.</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Heuer</surname>
<given-names>Josef G.</given-names>
</name>
</contrib>
<aff id="aff1">Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><bold>Correspondence:</bold> Dr. Josef G. Heuer, <addr-line>Biotherapeutic Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, 355 East Merrill Street, Indianapolis, IN 46285</addr-line>. Email: <email>jheuer@lilly.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>10</month>
<year>2017</year>
</pub-date>
<volume>29</volume>
<issue>2</issue>
<fpage>477</fpage>
<lpage>491</lpage>
<history>
<date date-type="received">
<day>6</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 by the American Society of Nephrology</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<self-uri xlink:href="ASN.2017040385.pdf" xlink:title="pdf"></self-uri>
<abstract>
<p>Progress in research and developing therapeutics to prevent diabetic kidney disease (DKD) is limited by a lack of animal models exhibiting progressive kidney disease. Chronic hypertension, a driving factor of disease progression in human patients, is lacking in most available models of diabetes. We hypothesized that superimposition of hypertension on diabetic mouse models would accelerate DKD. To test this possibility, we induced persistent hypertension in three mouse models of type 1 diabetes and two models of type 2 diabetes by adeno-associated virus delivery of renin (ReninAAV). Compared with LacZAAV-treated counterparts, ReninAAV-treated type 1 diabetic Akita/129 mice exhibited a substantial increase in albumin-to-creatinine ratio (ACR) and serum creatinine level and more severe renal lesions. In type 2 models of diabetes (C57BKLS <italic>db/db</italic> and BTBR <italic>ob/ob</italic> mice), compared with LacZAAV, ReninAAV induced significant elevations in ACR and increased the incidence and severity of histopathologic findings, with increased serum creatinine detected only in the ReninAAV-treated <italic>db/db</italic> mice. The uninephrectomized ReninAAV <italic>db/db</italic> model was the most progressive model examined and further characterized. In this model, separate treatment of hyperglycemia with rosiglitazone or hypertension with lisinopril partially reduced ACR, consistent with independent contributions of these disorders to renal disease. Microarray analysis and comparison with human DKD showed common pathways affected in human disease and this model. These results identify novel models of progressive DKD that provide researchers with a facile and reliable method to study disease pathogenesis and support the development of therapeutics.</p>
</abstract>
<kwd-group>
<kwd>chronic diabetic complications</kwd>
<kwd>diabetic nephropathy</kwd>
<kwd>diabetic glomerulopathy</kwd>
<kwd>electron microscopy</kwd>
<kwd>hypertension</kwd>
</kwd-group>
<counts>
<fig-count count="7"></fig-count>
<table-count count="5"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="43"></ref-count>
<page-count count="15"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>February 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>